Koers Achieve Life Sciences Inc Nasdaq
Aandelen
US0044681049
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | - | Omzet 2025 * | 257K 239K | Marktkapitalisatie | 162 mln. 151 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -33 mln. -30,63 mln. | Nettowinst (verlies) 2025 * | -37 mln. -34,34 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 631 x |
K/w-verhouding 2024 * |
-4,46
x | K/w-verhouding 2025 * |
-4,84
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 90,59% |
Recentste transcriptie over Achieve Life Sciences Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Bencich
CEO | Chief Executive Officer | 47 | 01-08-14 |
Richard Stewart
CHM | Chairman | 65 | 01-05-15 |
Cindy Jacobs
PSD | President | 66 | 01-08-08 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Vaughn Himes
BRD | Director/Board Member | 63 | 14-03-22 |
Thomas King
BRD | Director/Board Member | 69 | 29-03-23 |
Cindy Jacobs
PSD | President | 66 | 01-08-08 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,69% | 47,9 mld. | |
+47,58% | 41,42 mld. | |
-3,46% | 40,7 mld. | |
-6,20% | 28,92 mld. | |
+9,17% | 25,55 mld. | |
-20,42% | 19,27 mld. | |
+0,17% | 12,15 mld. | |
+28,07% | 12,14 mld. | |
-1,24% | 11,99 mld. |